On March 15, 2019 Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, reported that Dr. Robert E. Martell, Head of Research & Development, will present a pipeline update at Oncology Meeting Innovation’s (OMI’s) 6th Annual Summit on Hematologic Malignancies on Saturday, March 16th, 11:10 a.m. PDT at the Fairmont Château in Whistler, British Columbia, Canada (Press release, Curis, MAR 15, 2019, View Source [SID1234534396]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The slides of the presentation will be available on the Company’s website: www.curis.com on the same day at 9:00 am EDT.